Latest Asx Market Updates News

Page 2 of 11
Austral Resources Australia Ltd has resumed trading on the ASX following news of a significant capital raising and a strategic investor commitment, signaling renewed confidence in the company’s future.
Maxwell Dee
Maxwell Dee
19 Feb 2026
Argenica Therapeutics has reported a significant increase in its half-year loss to $3.82 million, driven by reduced revenue and higher research and development expenses. The company continues to invest heavily in its neuroprotective drug candidate ARG-007 amid ongoing clinical trials.
Ada Torres
Ada Torres
11 Feb 2026
Celsius Resources Limited has had its trading suspension lifted following an announcement about its Supreme Court application challenging the validity of its prior auditor's 2011 resignation.
Maxwell Dee
Maxwell Dee
9 Feb 2026
Celsius Resources has voluntarily suspended its shares on the ASX pending a Supreme Court ruling on the validity of its former auditor's 2011 resignation. The suspension will last until the court decision or 9 February 2026, whichever comes first.
Maxwell Dee
Maxwell Dee
4 Feb 2026
RPMGlobal’s acquisition by Caterpillar has cleared its final legal hurdle, with shares suspended and a $5 per share cash payout set for mid-February.
Sophie Babbage
Sophie Babbage
4 Feb 2026
Kula Gold reports standout high-grade gold results from Mt Palmer, completes Wozi niobium drilling, and advances Westonia divestment amid Forrestania’s takeover nearing completion.
Maxwell Dee
Maxwell Dee
30 Jan 2026
Synertec Corporation Limited has reported a robust 25% increase in revenue for FY26 Q2 alongside a significant turnaround to positive operating cashflow, underpinned by strong project pipelines and strategic partnerships.
Sophie Babbage
Sophie Babbage
30 Jan 2026
Findi Limited’s trading suspension is expected to end on 30 January 2026 following satisfactory responses to ASX queries, reopening the stock to market activity.
Claire Turing
Claire Turing
29 Jan 2026
Decidr AI Industries has solidified its position in the agentic AI market by completing strategic acquisitions and launching its DecidrOS platform, achieving a 60% revenue increase in the December quarter.
Sophie Babbage
Sophie Babbage
29 Jan 2026
Racura Oncology reported a transformative quarter with key scientific discoveries, expanded clinical programs, and a robust cash position of $20.94 million, setting the stage for pivotal cancer trials in 2026.
Ada Torres
Ada Torres
29 Jan 2026
3D Energi Limited has voluntarily suspended trading of its shares on the ASX as it navigates funding challenges and the future of its VIC/P79 exploration permit. The suspension will last until early February or until further updates are provided.
Maxwell Dee
Maxwell Dee
27 Jan 2026
Bluescope Steel has announced a special unfranked dividend of AUD 1.00 per share, payable in late February 2026, signaling a notable return to shareholders outside its regular dividend schedule.
Maxwell Dee
Maxwell Dee
14 Jan 2026